Companies Pfizer

Pfizer

Chennai

Total Offices: 2

121,990 Total Employees

Year Founded: 1848

View Website

We're Hiring!

Healthcare Services 1

View all jobs

Pfizer Innovation & Technology Culture

Pfizer Employee Perspectives

It’s a multi-disciplinary approach that allows us to integrate cutting-edge technologies like AI and machine learning into our research processes, enabling us to make faster and bigger strides in understanding and treating cancer.

Mack MacKenzie, VP of Digital for Oncology, Business Innovation and Enterprise AI

From the article: Pfizer Leadership: How The Company is Redefining the World’s Approach to Cancer Research

What People Are Saying About Pfizer

Product Innovation: Recent records of NME approvals and first-in-class launches (e.g., U.S. approvals of Beqvez gene therapy and Hympavzi) highlight visible output across modalities. The Seagen acquisition further expands novel oncology formats like ADCs and late-stage assets.
Investment in R&D: Company guidance and filings show sustained double‑digit‑billion annual R&D investment (roughly $10.7–$11.7B for 2025). This consistent funding underpins a 100+ program pipeline spanning oncology, vaccines, inflammation, and internal medicine.
Emerging Technology Adoption: Company KPIs note faster cycle times (around 5.1 years from first‑in‑human to approval in 2023) alongside a scale‑up of large‑scale digital solutions across R&D and manufacturing. These signals point to systematic use of AI/digital to accelerate development and operations.